Sunday, October 09, 2022 12:10:42 AM
This is going to be one hell of a ride my friends. $RVVTF
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320789/
More and more data keeps getting tripped over.
Note, the medical research industry does not typically look at stuff that has expired patents, is not patent-able, and they miss some much, as they search for the holy grail they print billions of dollars with selling dangerous side effect drugs. In fact they even miss 2018 NIH research zinc and the immune system, NAC, and recently on old school Baking Soda (NaHCO2) (used with water to kill mold in flooded houses, LOL, and sold for snake oil dollar prices at Home depot under trade names for Mold killer, that is traces of baking soda and water, for $50/gallon).
Consumers are that gullible..., due to a lack of education in the sciences...
Soo, the new find on Reddit,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320789/
NAC, the lets call it, weaker version of $RVVTF Bucci!!!
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Di...
N-acetylcysteine (NAC), which is an acetylated cysteine compound, has aroused scientific interest for decades due to its important medical applications. It also represents a nutritional supplement in the human diet. NAC is a glutathione precursor and shows antioxidant and anti-inflammatory activities. In addition to the uses quoted in the literature, NAC may be considered helpful in therapies to counteract neurodegenerative and mental health diseases. Furthermore, this compound has been evaluated for its neuroprotective potential in the prevention of cognitive aging dementia. NAC is inexpensive, commercially available and no relevant side effects were observed after its administration. The purpose of this paper is to give an overview on the effects and applications of NAC in Parkinson’s and Alzheimer’s disorders and in neuropathic pain and stroke.
Keywords: #N-acetylcysteine, #glutathione precursor, oxidative stress, #Parkinson’s disease, #Alzheimer’s disease, #neuropathic pain, #stroke
What about Bucillamine?
Bucci is 16 times more effective than NAC...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320789/
More and more data keeps getting tripped over.
Note, the medical research industry does not typically look at stuff that has expired patents, is not patent-able, and they miss some much, as they search for the holy grail they print billions of dollars with selling dangerous side effect drugs. In fact they even miss 2018 NIH research zinc and the immune system, NAC, and recently on old school Baking Soda (NaHCO2) (used with water to kill mold in flooded houses, LOL, and sold for snake oil dollar prices at Home depot under trade names for Mold killer, that is traces of baking soda and water, for $50/gallon).
Consumers are that gullible..., due to a lack of education in the sciences...
Soo, the new find on Reddit,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320789/
NAC, the lets call it, weaker version of $RVVTF Bucci!!!
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Di...
N-acetylcysteine (NAC), which is an acetylated cysteine compound, has aroused scientific interest for decades due to its important medical applications. It also represents a nutritional supplement in the human diet. NAC is a glutathione precursor and shows antioxidant and anti-inflammatory activities. In addition to the uses quoted in the literature, NAC may be considered helpful in therapies to counteract neurodegenerative and mental health diseases. Furthermore, this compound has been evaluated for its neuroprotective potential in the prevention of cognitive aging dementia. NAC is inexpensive, commercially available and no relevant side effects were observed after its administration. The purpose of this paper is to give an overview on the effects and applications of NAC in Parkinson’s and Alzheimer’s disorders and in neuropathic pain and stroke.
Keywords: #N-acetylcysteine, #glutathione precursor, oxidative stress, #Parkinson’s disease, #Alzheimer’s disease, #neuropathic pain, #stroke
What about Bucillamine?
Bucci is 16 times more effective than NAC...
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
